These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 13899716)

  • 1. The effects of lysergic acid diethylamide (LSD-25) upon the histochemical reactions for cholinesterase in the central nervous system.
    GOLDBERGER M
    Acta Anat (Basel); 1961; 46():185-91. PubMed ID: 13899716
    [No Abstract]   [Full Text] [Related]  

  • 2. Some CNS electrophysiologic effects of serotonin and lysergic acid diethylamide.
    GUNN CG
    Psychiatr Res Rep Am Psychiatr Assoc; 1960 Jan; 12():194-203. PubMed ID: 13851827
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of LSD on reaction times in a conditioned avoidance reaction and in the analgesia test].
    TAESCHLER M; WEIDMANN H; CERLETTI A
    Helv Physiol Pharmacol Acta; 1960; 18():43-9. PubMed ID: 13836568
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholinesterase, dlysergic acid diethylamide, and 2-bromolysergic acid diethylamide.
    BERTINO JR; KLEE GD; WEINTRAUB W
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1959; 20():218-22. PubMed ID: 13799991
    [No Abstract]   [Full Text] [Related]  

  • 5. Analeptic action of lysergic acid diethylamide (LSD-25) against pentobarbital.
    APTER JT
    AMA Arch Neurol Psychiatry; 1958 Jun; 79(6):711-5. PubMed ID: 13532082
    [No Abstract]   [Full Text] [Related]  

  • 6. The inhibition of human brain acetylcholinesterase by LSD-25 and JB-336 in vitro.
    Bajgar J; Patocka J; Zizkovský V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1971; 14(4):417-23. PubMed ID: 5291385
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of the neurophysiological effects of lysergic acid diethylamide (LSD) and other phychotomimetic agents.
    EVARTS EV
    Ann N Y Acad Sci; 1957 Mar; 66(3):479-95. PubMed ID: 13425237
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental contribution to the problem of possible crossed tolerance between psychotic drugs of different structure].
    MISSERE G; TONINI G
    Boll Soc Ital Biol Sper; 1959 Sep; 35():1119-20. PubMed ID: 14422940
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of LSD on the central nervous system (review)].
    Popova EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(3):457-62. PubMed ID: 4978646
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 11. THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO LYSERGIC ACID TARTRATE (BOL-148) ON SPECIFIC CHOLINESTERASE AND MONOAMINE OXIDASE OF RAT LIVER AS POSSIBLE FACTORS IN THE MECHANISM OF HALLUCINATION. A HISTOCHEMICAL STUDY.
    NANDY K; SHANTHAVEERAPPA TR; BOURNE GH
    Acta Histochem; 1964 Apr; 17():259-67. PubMed ID: 14190338
    [No Abstract]   [Full Text] [Related]  

  • 12. The preservation of substance P by lysergic acid diethylamide.
    KRIVOY WA
    Br J Pharmacol Chemother; 1957 Sep; 12(3):361-4. PubMed ID: 13460245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of LSD and reserpine on the central nervous system of the cat; the antagonism between LSD and chlorpromazine or reserpine.
    TAKAGI H; YAMAMOTO S; TAKAORI S; OGIU K
    Jpn J Pharmacol; 1958 Mar; 7(2):119-34. PubMed ID: 13563000
    [No Abstract]   [Full Text] [Related]  

  • 14. An experimental study of the participation of the sympathetic nervous system in the lysergic acid diethylamide (LSD) reaction in cats.
    ELDER JT; DILLE JM
    J Pharmacol Exp Ther; 1962 May; 136():162-8. PubMed ID: 13889792
    [No Abstract]   [Full Text] [Related]  

  • 15. Placebo reactions in a study of lysergic acid diethylamide (LSD-25).
    LINTON HB; LANGS RJ
    Arch Gen Psychiatry; 1962 May; 6():369-83. PubMed ID: 14465662
    [No Abstract]   [Full Text] [Related]  

  • 16. HISTOCHEMICAL STUDIES ON THE MECHANISM OF ACTION OF THE HALLUCINOGENS D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO-LYSERGIC ACID TARTRATE (BOL-148) IN RAT BRAIN.
    SHANTHAVEERAPPA TR; NANDY K; BOURNE GH
    Acta Neuropathol; 1963 Sep; 3():29-39. PubMed ID: 14197655
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lesions of the central nervous system in Carassius auratus caused by serotonin and the protective action of lysergic acid diethylamide].
    BRUSA A; GIANNIOTTI G; SACCHI U
    Boll Soc Ital Biol Sper; 1956 Jun; 32(6):438-41. PubMed ID: 13374116
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats].
    MAFFII G
    Farmaco Sci; 1959 Jul; 14():503-15. PubMed ID: 13853753
    [No Abstract]   [Full Text] [Related]  

  • 20. [D-Lysergic acid diethylamide (LSD). 2. Clinical aspects].
    GROF S; VOJTECHOVSKY M; VOTAVA Z
    Lek Veda Zahr; 1960; 11():245-51 contd. PubMed ID: 13858660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.